NCT02106260View on ClinicalTrials.gov

First-in-Human Study of CLS003 ICVT in Subjects With Cutaneous Warts

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

April 30, 2014

Conditions
Cutaneous Warts
Interventions
DRUG

CLS003

Trial Locations (1)

Unknown

Centre for Human Drug Research, Zernikedreef 8

All Listed Sponsors
lead

Maruho Co., Ltd.

INDUSTRY

NCT02106260 - First-in-Human Study of CLS003 ICVT in Subjects With Cutaneous Warts | Biotech Hunter | Biotech Hunter